| Symbol |
Name |
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ATM
|
ATM serine/threonine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNE1
|
cyclin E1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
E2F1
|
E2F transcription factor 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EP300
|
E1A binding protein p300
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IRS1
|
insulin receptor substrate 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MSH6
|
mutS homolog 6
|
|
NF1
|
neurofibromin 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
|
|
PIK3C2G
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PTEN
|
phosphatase and tensin homolog
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RB1
|
retinoblastoma 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
TP53
|
tumor protein p53
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
